everplay Group: Strong Margins, Dislocated Price, and a High-Conviction Growth Pipeline

The current setup for European equities demands a disciplined, fundamental approach. The market is fairly valued, which means the traditional margin of safety has largely disappeared. This environment favors deep analysis over market timing. As one recent assessment notes, the price/fair value estimate of the European market is one chart that goes someway to answering this. We're as close to 1, which means the market is fairly valued, as we've been in almost a year. The implication is clear: buying at today's levels offers little protection against volatility. The danger is not permanent capital loss, but the risk of falling into the red if sentiment shifts.

Against this backdrop, the long-term record of European small caps becomes a critical anchor. The MSCI Europe Small Cap index has a long-term track record of outperformance vs. most other equity indices, with cumulative returns over the past 25 years surpassing even the S&P 500. This historical edge suggests the asset class possesses a durable competitive moat, driven by the high growth potential of its constituents. Yet, that growth premium is not guaranteed. The market's current fair valuation means any future outperformance will be earned, not given.

This is where the value investor's framework must sharpen. With broad market appeal, the focus must narrow to individual companies with wide economic moats and intrinsic value that is not yet reflected in the price. Screening for undervaluation provides a starting point, but it is only the first filter. The second, equally important, is management conviction. When insiders are buying, it signals they see value where others may not. The combination of a company trading at a discount to its estimated fair value and a boardroom betting on its future is a powerful, if not infallible, signal. In a market without a margin of safety, these are the signals that must be followed.

Case Study 1: everplay group - Quality, Valuation, and the Moat

The story at everplay is one of quality improvement masking a headline that triggered a knee-jerk sell-off. The company reported double-digit profit growth and strong margin expansion in its final results for the year ended December 2025. Yet, its shares fell 13% to 225p on the news. The market's reaction was a classic case of focusing on the wrong signal. The flat headline revenue of £166 million was not a surprise; it was the direct result of a deliberate strategic shift to exit its low-margin physical distribution business. As Peel Hunt noted, this move was anticipated and is the very reason for the improved profitability.

Zooming in on the numbers reveals a company strengthening its economic moat. The gross profit rose 10% to £76.3 million, with the margin expanding by 4.4 percentage points to 46.0%. This dramatic improvement in the quality of earnings is the core of the investment thesis. It means everplay is now generating more profit from each pound of sales, a hallmark of a durable business model. The underlying momentum was also building through the year, with revenue accelerating 9% in the second half after a 10% decline in the first half. The company's focus is shifting to higher-margin digital releases, where new release revenues were up 80% year on year.

Financially, the company is in a solid position. It ended the year with cash and cash equivalents of £51.9 million, providing a buffer for its ambitious pipeline. The board also maintained its dividend, raising the total payout for the year to 2.9 pence per share. This combination of strong cash generation and a disciplined capital allocation policy supports the long-term compounding story.

The valuation now offers a potential margin of safety. Despite the profit surge, the stock trades at a forward price-to-earnings ratio of just 10 times its 2026 earnings estimate. That multiple is low for a company with a track record of double-digit profit growth and a clear path to future expansion. The catalyst is the execution of its pipeline of at least 15 new games and apps, including first-party intellectual property. Titles like Hell Let Loose: Vietnam, with its half-million Steam wishlist entries, represent the kind of future cash flow that can drive the stock higher. For the value investor, everplay presents a company trading at a discount to its intrinsic value, where the business quality is demonstrably improving.

Case Study 2: Bergman & Beving AB - Insider Conviction in a Steady Business

The story at Bergman & Beving AB is one of quiet stability meeting a powerful insider signal. The company operates in a defensive sector, which provides a natural moat against economic cycles. This resilience is a key attribute for long-term compounding, especially in a market where the overall margin of safety has vanished. The recent operational setup appears intact, with the company delivering an earnings beat that prompted a wave of insider buying.

The conviction from within is hard to ignore. In the last 90 days, the company saw net insider buying totaling 154,878 SEK, with three executives making purchases. This activity followed a recent earnings report where the company exceeded expectations. The transactions are significant in both scale and timing. The CFO bought shares at 52.94 SEK, while the CEO and another senior executive purchased at prices above 386 SEK. These are not token purchases; they represent a concentrated bet by those who know the business best. In the value investor's lexicon, this is a classic signal that insiders see intrinsic value where the market may not.

Yet, the market's reaction has been the opposite of conviction. The stock has experienced a notable price decline over the past three months. This disconnect between strong operational performance and falling share price creates a potential opportunity. It suggests the market is focusing on short-term noise or broader sector headwinds, overlooking the underlying stability and the management's confidence. For a disciplined investor, this is the setup where patience and fundamental analysis are rewarded.

The bottom line is that Bergman & Beving offers a steady business with a clear insider endorsement. The defensive nature of its operations provides a foundation for resilience, while the recent insider buying acts as a powerful vote of confidence in its future. In a market that is fairly valued, such signals from those closest to the company are among the most reliable indicators of where intrinsic value may lie.

Case Study 3: AddLife (formerly ChemoMetec) - A High-Margin Specialist with a Clear Moat

AddLife presents a classic case of a high-quality, niche specialist with a durable business model. The company operates in the healthcare sector, focusing on cell counting and analysis instruments, consumables, and services. Its market capitalization of DKK 17.5 billion marks it as a significant player in its specialized field. The core of its competitive advantage lies in its recurring revenue stream. By generating the majority of its income from consumables and services, AddLife locks in customers into a long-term relationship. This model creates a predictable cash flow and a wide economic moat, as switching costs for labs are high and the quality of its instruments is paramount.

Financially, the company demonstrates exceptional operational discipline. Its gross profit margin has shown a clear upward trend, reaching 95.54% by the end of 2025. This staggering figure is the hallmark of a premium product with minimal variable cost, a key driver of intrinsic value. While operating expenses, particularly general and administrative costs, have increased over time, the sheer scale of the gross profit provides a robust buffer. This financial strength supports the company's ability to invest in its pipeline and maintain its technological edge.

Management's conviction in this intrinsic value is evident through recent insider activity. In January 2026, Johan Andersson purchased 4,733 shares for SEK 427,083. This transaction, made within the last three months, is a tangible signal that those closest to the business see a disconnect between the current share price and the underlying earnings power. It aligns with the broader pattern of insider buying noted for the company, reinforcing the signal of confidence.

The path to long-term compounding is clear. AddLife's model is built on recurring revenue from essential lab tools, a high-margin product, and a management team that is betting its own capital. In a market where the margin of safety is thin, this combination of a wide moat and insider conviction provides a compelling setup. The company's forecast for annual earnings growth of 22% offers a tangible target for future value creation, driven by its entrenched customer base and premium pricing power. For the value investor, AddLife is a specialist with a fortress-like business, where the numbers and the actions of those who run it point toward a future where the market price eventually catches up to the intrinsic value.

Synthesis and Forward Look: Catalysts and Risks

The investment thesis for these three European small caps converges on a single principle: intrinsic value is being overlooked. Each company presents a different path to that value. everplay is demonstrating it through a dramatic improvement in profitability, where the market initially misread a strategic pivot as stagnation. Bergman & Beving signals it through a powerful, concentrated bet by insiders who see value in a steady business. AddLife embodies it in a fortress-like model of high-margin, recurring revenue that generates exceptional cash flow. In a market where the margin of safety has largely disappeared, these are the signals a disciplined investor must follow.

The common thread is that success hinges on execution and stability. For everplay, the catalyst is the pipeline of new games and apps. The company has a clear roadmap with at least 15 new titles, including first-party IP, and a proven ability to generate high new-release revenues. The market's initial skepticism was based on a flat headline, but the real story is the quality of that revenue. The forward P/E of 10 times is a discount to its growth and margin expansion, but that gap will close only if the new releases meet or exceed expectations. The company's cash position provides a runway, but the execution of its growth plan is the key variable.

For Bergman & Beving, the catalyst is the stability of its core operations. The company's defensive sector provides a natural moat, but the recent price decline suggests the market is pricing in broader sector headwinds or cyclical fears. The insider buying is a vote of confidence in the underlying business model, but the stock's performance will likely track the resilience of its industrial equipment sales. Investors should monitor for signs of a stabilization in demand, as the company's ability to compound depends on maintaining its market position through economic cycles.

AddLife's catalyst is the sustainability of its extraordinary margins. With a gross profit margin near 96%, the company's model is built on premium products and essential lab services. The recent guidance adjustment for revenue is a reminder that even high-quality businesses face operational pressures. The key for investors is to assess whether the company can maintain its pricing power and operational discipline. The collaboration with Roche Diagnostics represents a potential growth vector, but the primary focus remains on executing its core business without letting costs erode its exceptional profitability.

The primary risk across all three is sector-specific volatility. everplay operates in a cyclical entertainment market where consumer spending can shift. Bergman & Beving is exposed to industrial production cycles. AddLife, while more defensive, is not immune to healthcare budget constraints. This is the environment in which these companies must compound. The value investor's role is to separate the noise from the signal. The evidence points to a setup where intrinsic value is present, but it will be earned through patient execution. The market's current fair valuation means there are no easy gains. Success will belong to those who can look past the short-term turbulence and see the durable businesses beneath.